TLN-4601 suppresses growth and induces apoptosis of pancreatic carcinoma cells through inhibition of Ras-ERK MAPK signaling
Authors
Paul M Campbell
Lineberger Comprehensive Cancer Center and Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill NC 27599-7295, USA
Nadia Boufaied
Thallion PharmaceuticalsInc., 7150 Alexander-Fleming, Montreal QC, H4S 2C8 Canada
James J Fiordalisi
Lineberger Comprehensive Cancer Center and Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill NC 27599-7295, USA
Adrienne D Cox
Lineberger Comprehensive Cancer Center and Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill NC 27599-7295, USA
Lineberger Comprehensive Cancer Center and Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill NC 27599-7295, USA
Pierre Falardeau
Thallion PharmaceuticalsInc., 7150 Alexander-Fleming, Montreal QC, H4S 2C8 Canada
Channing J Der
Lineberger Comprehensive Cancer Center and Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill NC 27599-7295, USA
Henriette Gourdeau
Thallion PharmaceuticalsInc., 7150 Alexander-Fleming, Montreal QC, H4S 2C8 Canada
DOI: https://doi.org/10.1186/1750-2187-5-18 | Journal eISSN: 1750-2187
Language: English
Published on: Nov 2, 2010
Published by: Danny N. Dhanasekaran
In partnership with: Paradigm Publishing Services
© 2010 Paul M Campbell, Nadia Boufaied, James J Fiordalisi, Adrienne D Cox, Pierre Falardeau, Channing J Der, Henriette Gourdeau, published by Danny N. Dhanasekaran
This work is licensed under the Creative Commons Attribution 4.0 License.